Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)

NARecruitingINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes
Interventions
DEVICE

Dexcom G6 Continous Glucose Monitoring Management

CGM data will be transmitted from the bedside iPhone to web-based platforms for: (1) Real-Time Management (via iPad-based FOLLOW app used by bedside RN and Digital Dashboard used by the remote monitoring team) and (2) Clinical Optimization (via CLARITY, by which a Diabetes RN Coordinator will conduct remote clinical management of patients from a central, Scripps Diabetes Hub.

DEVICE

Usual Care - Blinded Continuous Glucose Monitoring Management

CGM data will be blinded and used for evaluation purposes only. Glucose will be monitored via the hospital's standard POC testing protocol (i.e., prior to meals and at bedtime for patients who are eating, and every 4-6 waking hours if not eating). Glucose management in UC is designed to minimize differences between groups, aside from CGM monitoring.

Trial Locations (1)

91910

RECRUITING

Scripps Mercy Hospital, Chula Vista

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Scripps Whittier Diabetes Institute

OTHER